Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amerise Biosciences Ltd has informed BSE about a scheduled board meeting on May 5, 2026. The meeting will consider and approve the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026, along with the Auditors' Reports. This is a standard regulatory intimation under Regulation 29 of SEBI (LODR) Regulations, 2015. No specific financial figures or outcomes have been disclosed in this filing. The actual results will be announced after the board meeting takes place.
This is a routine filing that informs shareholders about an upcoming board meeting to approve annual results. No immediate impact on stock price until actual results are disclosed. Investors should await the outcome of the meeting expected on May 5, 2026.